The Risk of Myocardial Infarction in Patients with Atrial Fibrillation Taking a Direct Thrombin Inhibitor: Myths and Reality
The purpose of this review is to analyze the results of randomized clinical trials, meta-analyses of cohort and observational studies in real clinical practice on the influence of dabigatran etexilate on the risk of myocardial infarction in patients with atrial fibrillation. A pivotal RE-LY study on...
| Auteurs principaux: | , , |
|---|---|
| Format: | Article |
| Langue: | English |
| Publié: |
Столичная издательская компания
2020-05-01
|
| Collection: | Рациональная фармакотерапия в кардиологии |
| Sujets: | |
| Accès en ligne: | https://www.rpcardio.online/jour/article/view/2168 |